$5 Million ResMed Gift Supports Sleep Medicine at UC San Diego

October 29, 2015

The University of California, San Diego today announced a $5 million gift from locally based medical device company, ResMed Inc., to support sleep medicine research and care at the UC San Diego School of Medicine. The donation was made to the university in honor of ResMed’s founder and chairman of the board, Peter C. Farrell, PhD, DSc. ResMed is the global leader in pioneering new and innovative solutions for the diagnosis, treatment and management of sleep-disordered breathing, chronic obstructive pulmonary disease (COPD), and other key chronic diseases.

The funding, totaling $5 million, will establish the Peter C. Farrell Sleep Center of Excellence, in addition to the Peter C. Farrell Presidential Chair in Pulmonary Medicine. ResMed’s donation to establish the endowed chair was matched with an additional $500,000 from the University of California as part of the UC system’s Presidential Match for Endowed Chairs. … Read the full story from the UC San Diego Newsroom


Atul Malhotra, MDAtul Malhotra, MD, pictured at left, is professor and chair of the Division of Pulmonary and Critical Care Medicine and Director of Sleep Medicine at UC San Diego.

Drs. Richard Garfein, Antonino Catanzaro and Coworkers Report More Rapid Tests for Drug-Resistant TB

Researchers at University of California, San Diego School of Medicine have documented the accuracy of three new tests for more rapidly diagnosing drug-resistant forms of tuberculosis (TB), which are much harder and more expensive to treat and which, experts say, represent a major threat to global public health. … Read the full story from the UC San Diego Newsroom


DrAntoninoCatanzaro_100x122

Department of Medicine co-authors of the report are emeritus professor Antonino Catanzaro, MD, of the Division of Pulmonary and Critical Care Medicine; and professor Richard Garfein, PhD, MPH, and associate professor Timothy C. Rodwell, MD, PhD, MPH, of the Division of Global Public Health.

Dr. Richard GarfeinPictured are Drs. Catanzaro (top left) and Garfein (left).

Read the study report here.

Dr. Atul Malhotra Is American Thoracic Society President for 2015-2016

Dr. Atul MalhotraAtul Malhotra, MD, was installed as president of the American Thoracic Society (ATS) in a ceremony on May 19 during the ATS 2015 Plenary Session.

Dr. Malhotra is Kenneth M. Moser Professor, Chief of the Division of Pulmonary and Critical Care Medicine, and Director of Sleep Medicine in the Department of Medicine.

Read ATS press release

Dr. Rebecca Sell Receives ATS Young Investigator Award

Dr. Rebecca Sell

Dr. Rebecca Sell

Rebecca Sell, MD, associate director of the Internal Medicine Residency Program and assistant professor of medicine in the Division of Pulmonary and Critical Care Medicine, won an American Thoracic Society (ATS) 2014 Young Investigator Award for her presentation at the annual meeting of the Asian Pacific Society of Respirology (APSR) in Bali, Indonesia, November 13-16, 2014.

Her presentation was titled, “Difference in Outcomes between Senior Physician and Medicine Resident-led Code Blues.”

Dr. Sell was a chief medical resident in the UC San Diego Internal Medicine Residency Training Program in 2006-2007.

Dr. Rebecca Sell receiving award at 2014 APRS meeting.

Dr. Sell receiving the award. Photo by Atul Malhotra, MD.

On the APSR 2014 program faculty was Atul Malhotra, MD, Kenneth M. Moser Professor of Medicine, director of sleep medicine and chief of the UC San Diego Division of Pulmonary and Critical Care Medicine.

Dr. Malhotra, who received an ATS Young Investigator award in 2005, will serve as president of the ATS in 2015-2016.

Potential New Way to Suppress Tumor Growth Discovered

Researchers at the University of California, San Diego School of Medicine, with colleagues at the University of Rochester Medical Center, have identified a new mechanism that appears to suppress tumor growth, opening the possibility of developing a new class of anti-cancer drugs. … Read the full story from the UCSD Newsroom


Dr. Willis X. Li

Dr. Willis X. Li

Senior author of the study report in the Proceedings of the National Academy of Sciences is Willis X. Li, PhD, professor of medicine in the Division of Pulmonary & Critical Care Medicine and faculty member in the Biomedical Sciences graduate program.

Li’s UC San Diego Department of Medicine coauthors are postdoctoral fellow Pranabananda Dutta, PhD; pulmonary/critical care physician-scientist Jinghong Li, MD, PhD, and senior undergraduate student Jingtong Wang.

Coauthors Xiaoyu Hu, Amy Tsurumi and Hartmut Land are colleagues at the University of Rochester, where Li was a faculty member and researcher at the Wilmot Cancer Center before he joined the faculty at UC San Diego.

At the University of Rochester, LI received the 2008 Davey Memorial Award for Outstanding Cancer Research for his work in the cellular and molecular signaling in cancer development.

He is now principal investigator of an R01 research grant from the National Cancer Institute for the project, Epigenetic Tumor Induction by Heterochromatin Instability.

Citation for the study report:  

Xiaoyu Hu, Pranabananda Dutta, Amy Tsurumi, Jinghong Li, Jingtong Wang, Hartmut Land, and Willis X. Li. Unphosphorylated STAT5A stabilizes heterochromatin and suppresses tumor growth. PNAS 2013 ; published ahead of print June 3, 2013, doi:10.1073/pnas.1221243110  |  Abstract  |  Full text (PDF)

UC San Diego Medical Center among Nation’s Best in 2010

UC San Diego Medical Center – where discoveries are delivered every day – has once again delivered in the category of “top hospitals,” as ranked by U.S. News & World Report’s latest “America’s Best Hospitals” issue… Read the full story from the UCSD Newsroom.

Appreciation and a Fond Farewell to Dr. Ken Kaushansky

Kenneth Kaushansky, MD, MACPOn July 19, Dr. Ken Kaushansky officially begins his work as Senior Vice President for Health Sciences and Dean of the School of Medicine at Stony Brook University in New York.

When he announced his departure to the faculty and staff of the UCSD Department of Medicine on June 7, he described his new position as an opportunity to implement, on a larger scale, the successful programs that the Department of Medicine has instituted under his leadership here.

He called his years at UCSD a time of “incredible transition in our faculty, our leaders, our teaching programs, and our clinical impact.”

During Dr. Kaushansky’s tenure as Helen M. Ranney Distinguished Professor and Chair, the Department of Medicine expanded from 253 to over 420 faculty members, added four divisions, and recruited 11 division chiefs. Its annual budget grew from $86 million to nearly $150 million.

Dr. Robert Schooley“Dr. Kaushansky has been an outstanding Chair for this department,” said Dr. Robert “Chip” Schooley, Professor and Chief of the Division of Infectious Diseases and Vice Chair for Academic Affairs in the Department of Medicine.“

During his eight years as Chair, the medical house staff program became one of the most highly regarded programs in the country. New divisions in Hospital Medicine, Biomedical Informatics, Geriatrics, and Global Public Health were developed and research programs thrived throughout the Department,” Dr. Schooley said.

“In response to increasing interest in international medicine among the medical house staff, Dr. Kaushansky launched the Department’s Global Medicine Residency Program in 2009,” he said.“Dr. Kaushansky worked with his counterpart at the Universidade Eduardo Mondlane to establish a model program in international cooperation that has revitalized postgraduate medical training in the Republic of Mozambique.”


Dr. Kaushansky with Drs. Marisa Magaña, Emilia Noormahomed, and Robert Schooley in Mozambique Dr. Kaushansky on a global medicine planning trip to China.Dr. Kaushansky with Drs. Marisa Magaña, Emilia Noormahomed, and Robert Schooley in Mozambique (left); on global medicine program planning trip to China (right).

Since 2002, the Department’s NIH research funding has grown from $60 million to $113.6 million. It has more than twice as many complex multi-investigator program-project grants and career development awards granted to the junior faculty and fellows.

The Department has also boosted its showing in the “America’s Best Hospitals” rankings from U.S.News & World Report. In 2002, two subspecialty clinical programs ranked in the nation’s top 50: respiratory at 9th and cancer at 41st. In the most recent rankings, five subspecialties ranked in the top 50, including one (HIV/AIDS) in the top 10.

Dr. Greg Maynard“Ken was directly responsible for building up the strength of clinical care at UCSD,” said Dr. Greg Maynard (right), Health Sciences Professor of Medicine and Chief of the Division of Hospital Medicine.

“He recruited me here about 7-1/2 years ago, and in that time, the Hospital Medicine program has grown from 4 hospitalists to nearly 30, as just one example of that.”

“Dr Kaushansky nurtured my career here at UCSD,” said Dr. Pradipta Ghosh (below left), physician-scientist and Assistant Professor of Medicine in the Division of Gastroenterology.

Dr. Pradipta Ghosh“As a product of the Physician-Scientist Training Program,” she said, “I am one of those few who enjoyed special access to this busy department chair. His doors were always open. I recall having multiple consultations with him at various stages of my career as it grew here at UCSD.

“When the time came for me to choose where to spend the first decade of my young career as an independent investigator, it was his support and a match in our visions which tilted my decision in favor of UCSD,” she said.

“His tireless efforts at instilling the physician-scientist culture here in the Department of Medicine, both from top-down and bottom-up, have paved the path for many young folks like me to craft a career for themselves as physician-scientists,” Dr. Ghosh said.

Dr. John Carethers“Ken was the reason why I eventually accepted the GI Chief job at UCSD,” said Dr. John M. Carethers (right), now John G. Searle Professor and Chair of the Department of Internal Medicine at the University of Michigan.

When Dr. Kaushansky joined the UCSD faculty, Dr. Carethers was an associate professor of medicine in the Division of Gastroenterology. Dr. Carethers became division chief in 2004

“Ken … gave me enough autonomy to help grow the GI Division, gain a GI Center grant, coordinate well with the Cancer Center and other divisions, and allowed me to grow personally,” Dr. Carethers said. “The GI Division flourished under that mantra.

“We went to a clinical service chief structure, developed a new hierarchy for our administrative staff, started a robust web site, grew our fellowship, and survived many challenges over that time because of his support,” he said.

“Ken provided invaluable advice on my career,” Dr. Carethers said. “He was a great sounding board, not pretentious; encouraging, but never overprotective. I think he understood the value of growth and opportunity, something that is hard to come by these days.”

Dr. Patricia FinnDr. Patricia Finn (left), Professor and Chief of the Division of Pulmonary and Critical Care Medicine, described Dr. Kaushansky as “a tireless advocate for his faculty.”

“He is accessible 24/7 to offer support and guidance, which is huge to a new faculty member just moving cross country,” she said.

“On a personal note, when I had barely arrived here he was already nominating me for positions and committees to help me advance my career.”

Dr. Kirk Knowlton“His integrity, fairness, and open-mindedness built an environment of trust that allowed the substantial growth of the Department of Medicine during his tenure as Chair,” said Dr. Kirk U. Knowlton (right), Professor of Medicine and Chief of the Division of Cardiology.

“I am struck by how he has been able to hold the respect of so many people with widely disparate interests,” Dr. Knowlton said.

“This included people who were fully engaged in basic science and those who were busy taking excellent care of their patients; medical students and residents and post-graduate research fellows; administrators and faculty; and others over whom he might have had influence or who crossed his path.

“The people he has worked with knew that they could count on him to represent their interests in the context of the institution’s goals in a considered and reasonable manner while at the same time maintaining his vision of the future of the Department of Medicine.”

“He is a rare breed,” Dr. Maynard said. “I guess I’d call him a quadruple threat. An outstanding scientist, a superb clinician, a great educator, and an incredible leader and administrator to boot.

“While he is not really replaceable,” he said, “he has left an enduring legacy that stresses clinical and operational excellence, as well as research contributions.”

Dr. Finn said, “In addition to [his] world-class scientific reputation, Dr. Kaushansky is most respected for his character and vision.”

“He makes his department and faculty a priority, while striving to always do the right thing for the patients,” she said. “He will be most remembered for his infectious enthusiasm, upbeat attitude, and steady, insightful guidance of students and faculty.”

“He leaves an 8-year legacy that advanced the Department of Medicine in many ways,” said Dr. Carethers, “including growing faculty, changing the way residents learn, obtaining key recruitments for division chiefs and faculty, enhancing VA relations, and being an all out cheerleader for the Department.”

On June 21, Dr. Kaushansky was honored at a farewell reception hosted by David Brenner, M.D., Dean of the UCSD School of Medicine and Vice Chancellor, Health Sciences. In his remarks there, Dr. Kaushansky expressed his appreciation for “eight and a half years of good friends, challenges, and teamwork.”

Observing that he had been involved in recruiting many of the faculty members in the room, he said, “Everything at UCSD works toward recruiting great people.”

“It’s easy, at UCSD, to build things and to make a difference,” he said. “Everybody makes everyone else stronger.”

Dr. Kaushansky praised UCSD’s “incredible richness” of people, science, teaching, and clinical programs. “I’ve never seen more devotion to the three missions,” he said.

And now he looks ahead.

“In academic medicine, you get to re-craft yourself every ten years,” he said. “I’m looking forward to my newly-found steep learning curve.”

Dr. Kaushansky was honored at a tribute from the senior leaders of the Department of Medicine on July 11. There will be a tribute from all departmental staff, faculty, and house staff on a date to be selected.

“Although one could cite metric after metric by which his unceasing efforts strengthened the Department,” said Dr. Schooley, “what many of us think distinguished his tenure most was the way in which his ‘bottom up’ style of leadership brought out the best in all of us.

“The Department will benefit for many years to come from things he set in motion – as will each of its members from what we learned from his multifaceted demonstration of scholarship, integrity, imagination and dedication to his Department.”


Drs. Ken Kaushansky and Wolfgang Dillmann   Drs. Ken Kaushansky and Wolfgang DillmannDr. Kaushansky with newly designated Interim Chair Wolfgang Dillmann, M.D.

In the Media: Dr. Jose Loredo

Dr. Jose Loredo was part of the National Sleep Foundation team that polled over 1000 Americans to assess sleep habits in the United States. HealthDay reported the results of the poll in “Sleepless Nights Plague America,” which appeared in BusinessWeek and other media.

Jose Loredo, M.D., is Professor of Clinical Medicine in the Division of Pulmonary and Critical Care Medicine. He directs the UCSD Sleep Medicine Center.

Research Profile: Dr. Timothy Morris, Clinical and Research Specialist in VTE

Dr. Timothy MorrisTimothy Morris, MD, has received a 5-year R01 grant from the National Heart, Lung and Blood Institute for his study, “Deep vein thrombosis and chronic thrombotic venous disease.”

The goal of the study is to find out why deep vein thrombi fail to dissolve completely in some individuals, leaving them with blood clot remnants that become scars and obstruct blood flow.

This condition, called chronic thrombotic venous disease, can cause disfigurement and chronic leg pain.   |  Read the public abstract of Dr. Morris’s grant

Dr. Morris, Professor of Clinical Medicine in the Division of Pulmonary & Critical Care Medicine, is a clinical and research specialist in venous thromboembolism (VTE).

He helped create the VTE prevention protocols for which the UCSD Medical Center has won national recognition.

Dr. Morris has received a number of honors and research funding awards for his work.

He was recently awarded the American College of Chest Physicians and The CHEST Foundation “Grant in Venous Thromboembolism” for 2009-2011 for a multicenter project entitled “User-Friendly VTE Prophylaxis.”In May of this year, the American Thoracic Society honored Dr. Morris with the “Certificate of Achievement as the Clinical Expert in Pulmonary Embolism.”

The California Thoracic Society named him Outstanding Clinician for 2008.

In 2003, Dr. Morris was awarded the first-ever “Distinguished Scholar in Thrombosis” by The CHEST Foundation of the American College of Chest Physicians.

The award, given for his project “Learning From Ourselves: Application of the Continuous Quality Improvement Model for the Management of Pulmonary Embolism,” was accompanied by a four-year salary support grant.

Dr. Morris is clinical service chief of the pulmonary and critical care program at the Hillcrest campus of the UCSD Medical Center. In addition, he is Medical Director of Respiratory Care and the Pulmonary Function Laboratory.

More Information